NCT03617627

Brief Summary

Chronic pelvic pain is a serious health condition with an estimated prevalence of 15% women worldwide.Treatment is a challenge given the different pain generators described. It is important to develop self-management interventions to reduce the frustration associated with its management.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
44

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 23, 2018

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

July 31, 2018

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 6, 2018

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 21, 2018

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 29, 2019

Completed
Last Updated

March 4, 2020

Status Verified

March 1, 2020

Enrollment Period

3 months

First QC Date

July 31, 2018

Last Update Submit

March 3, 2020

Conditions

Keywords

chronic painwomenself-management

Outcome Measures

Primary Outcomes (2)

  • Perceived health-related quality of life

    Health-related quality of life will be assessed using the EuroQol-5D. This scale consists of a descriptive system and the EQ visual analogue scale. The descriptive system comprises the following 5 dimensions: mobility, self-care, usual activities, oain/discomfort and anxiety/depression. Each dimension has 3 levels: no problems, some problems, extreme problems. Higher scores indicate more problems. In the visual analogue scale the patient rate the pain from 100 (best imaginable health state) to 0 (worst imaginable health state). Higher values represent a better health state.

    Change from baseline health-related quality of life at 7 weeks

  • Change in coping strategies

    Coping strategies will be evaluated using the Coping Strategies Questionnaire (CSQ). It assesses eight different coping strategies for pain which describe two types of coping: adaptive coping (diverting Attention, coping self-statements, ignoring sensations, reinterpreting pain sensation, hoping and cognitive distracting) and maladaptive coping (catastrophizing, and faithing and praying). Participants score each item using a 7-point scale to indicate how often they use that strategy to manage their pain (0 never, 3 sometimes, and 6 always)

    Change from baseline coping strategies at 7 weeks

Secondary Outcomes (4)

  • Change in performance of activities

    Change from baseline self-perceived performance at 7 weeks

  • Change in activity levels

    Change from baseline self-reported activity levels at 7 weeks

  • Change in anxiety levels.

    Change from baseline anxious symptoms at 7 weeks

  • Change in depressive symptoms

    Change from baseline depressive symptoms at 7 weeks

Study Arms (2)

Experimental group

EXPERIMENTAL

Patients will be included in a self-management intervention.

Behavioral: Self-management intervention

Control group

NO INTERVENTION

Patients will receive a booklet with information.

Interventions

Self-management intervention will include presentation and discussion of various topics regarding chronic pain mechanisms and pain self-monitoring. The intervention will also incorporate a task-oriented approach focused on relevant activities in order to acquire coping skills.

Experimental group

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of chronic pelvic pain with at least 6 months of evolution

You may not qualify if:

  • Active urogenital infection
  • Pregnancy
  • Cancer
  • Dementia
  • A surgical intervention involving lumbo-pelvic region over the past year

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Physical Therapy

Granada, 18071, Spain

Location

MeSH Terms

Conditions

Chronic Pain

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Marie Carmen Valenza, phD

    Universidad de Granada

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD

Study Record Dates

First Submitted

July 31, 2018

First Posted

August 6, 2018

Study Start

July 23, 2018

Primary Completion

October 21, 2018

Study Completion

April 29, 2019

Last Updated

March 4, 2020

Record last verified: 2020-03

Locations